MB, Levis & Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
MB, Levis & Associates's AMGN Position: Q3 2026 in Review
MB, Levis & Associates increased its Amgen (AMGN) stake by 4.4% in Q3 2026, buying an estimated $51.4K and bringing the position to 3,057 shares worth $1.29M. The position accounts for 0.47% of the portfolio, ranked #35.
MB, Levis & Associates first reported a position in AMGN in Q4 2022 and has held it in 16 quarters since. 3,271 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- MB, Levis & Associates held 3,057 shares of Amgen worth $1.29M as of Q3 2026.
- MB, Levis & Associates bought 129 Amgen shares in Q3 2026, an estimated $51.4K.
- Amgen made up 0.47% of MB, Levis & Associates's portfolio in Q3 2026, its #35 holding.
- MB, Levis & Associates first reported a position in Amgen in Q4 2022 and has held it in 16 quarters since.
- 3,271 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on MB, Levis & Associates's 13F filing for Q3 2026, filed 16 Oct 2026.